{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:43:03Z","timestamp":1773160983799,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.endinu.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T17:53:54Z","timestamp":1526752434000},"page":"380-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain"],"prefix":"10.1016","volume":"65","author":[{"given":"Ignacio","family":"Conget","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00edn-Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Roze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Delbaere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Ampudia-Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2018.03.008_bib0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.avdiab.2013.07.007","article-title":"Direct cost of diabetes mellitus and its complications in Spain (SECCAID Study: Spain estimated cost Ciberdem-Cabimer in Diabetes)","volume":"29","author":"Crespo","year":"2013","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endinu.2018.03.008_bib0160","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.endonu.2014.08.003","article-title":"Grupo de Trabajo de Nuevas Tecnolog\u00edas de la Sociedad Espa\u00f1ola; Grupo de Diabetes de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n; Sociedad Espa\u00f1ola de Endocrinolog\u00eda Pedi\u00e1trica Position statement on efficiency of technologies for diabetes management","volume":"61","author":"Mart\u00edn-Vaquero","year":"2014","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endinu.2018.03.008_bib0165","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/dia.2017.2503","article-title":"Insulin pumps","volume":"19","author":"Pickup","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2018.03.008_bib0170","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.endinu.2017.04.006","article-title":"Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain","volume":"64","author":"Gim\u00e9nez","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endinu.2018.03.008_bib0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endinu.2018.03.008_bib0180","article-title":"en nombre del Grupo de Tecnolog\u00edas Aplicadas a la Diabetes de la SED y de la SEEP SED-SEEP Consensus document on the use of continuous glucose monitoring in Spain","author":"Gim\u00e9nez","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endinu.2018.03.008_bib0185","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.endinu.2018.03.008_bib0190","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.endinu.2018.03.008_bib0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jval.2014.07.007","article-title":"Validation of the IMS CORE Diabetes Model","volume":"17","author":"McEwan","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.endinu.2018.03.008_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.gaceta.2009.07.011","article-title":"Propuesta de gu\u00eda para la evaluaci\u00f3n econ\u00f3mica aplicada a las tecnolog\u00edas sanitarias","volume":"24","author":"L\u00f3pez Bastida","year":"2010","journal-title":"Gac Sanit"},{"key":"10.1016\/j.endinu.2018.03.008_bib0205","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1185\/030079905X65349","article-title":"Review of the cost of diabetes complications in Australia, Canada, France, Germany Italy and Spain","volume":"21","author":"Ray","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.endinu.2018.03.008_bib0210","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3111\/13696998.2013.803110","article-title":"The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index \u226530kg\/m(2) in Spain","volume":"16","author":"Fonseca","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.endinu.2018.03.008_bib0215","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1524-4733.2009.00507.x","article-title":"Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe\u2014the HEALTH model","volume":"12","author":"Schwander","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.endinu.2018.03.008_bib0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.recesp.2013.12.016","article-title":"Health care and multiple care costs in the treatment of patients with symptomatic chronic heart failure in Spain","volume":"67","author":"Delgado","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.endinu.2018.03.008_bib0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1472-6963-12-315","article-title":"Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands Spain","volume":"12","author":"Lopez-Bastida","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.endinu.2018.03.008_bib0230","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1093\/ndt\/gfr088","article-title":"Cost analysis of the Spanish renal replacement therapy programme","volume":"26","author":"Villa","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.endinu.2018.03.008_bib0235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1590\/S1135-57272006000600008","article-title":"An\u00e1lisis coste-utilidad de las bombas de ultipl frente a m\u00faltiples dosis diarias en pacientes con diabetes mellitus tipo 1 en Espa\u00f1a","volume":"80","author":"CongetDonlo","year":"2006","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.endinu.2018.03.008_bib0240","unstructured":"Portal estad\u00edstico. Ministerio de Sanidad, Servicio Sociales e Igualdad. Available at: http:\/\/pestadistico.inteligenciadegestion.msssi.es\/publicoSNS\/comun\/DefaultPublico.aspx [accessed September 2016]."},{"key":"10.1016\/j.endinu.2018.03.008_bib0245","unstructured":"eSalud. Informaci\u00f3n econ\u00f3mica del sector sanitario. Available at: http:\/\/www.oblikue.com\/bddcostes\/ [accessed September 2016]."},{"key":"10.1016\/j.endinu.2018.03.008_bib0250","unstructured":"Informe sobre la ceguera en Espa\u00f1a. Available at: http:\/\/www.fundacionretinaplus.es\/images\/documentos\/Informe_Ceguera.pdf."},{"key":"10.1016\/j.endinu.2018.03.008_bib0255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00592-014-0598-7","article-title":"Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study","volume":"51","author":"Hommel","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.endinu.2018.03.008_bib0260","doi-asserted-by":"crossref","first-page":"e618039","DOI":"10.1155\/2013\/618039","article-title":"The cost of diabetes-related complications: registry-based analysis of days absent from work","volume":"2013","author":"S\u00f8rensen","year":"2013","journal-title":"Econ Res Int"},{"key":"10.1016\/j.endinu.2018.03.008_bib0265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jval.2014.03.003","article-title":"Review of utility values for economic modeling in type 2 diabetes","volume":"17","author":"Beaudet","year":"2014","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.endinu.2018.03.008_bib0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dia.2012.0288","article-title":"Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study","volume":"15","author":"N\u00f8rgaard","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2018.03.008_bib0275","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1185\/030079906X115757","article-title":"Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes","volume":"22","author":"Currie","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.endinu.2018.03.008_bib0280","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0213-9111(02)71933-X","article-title":"\u00bfQu\u00e9 es una tecnolog\u00eda eficiente en Espa\u00f1a?","volume":"16","author":"Sacrist\u00e1n","year":"2002","journal-title":"Gac Sanit"},{"key":"10.1016\/j.endinu.2018.03.008_bib0285","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3111\/13696998.2015.1113979","article-title":"Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective","volume":"19","author":"Roze","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.endinu.2018.03.008_bib0290","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s13300-017-0294-z","article-title":"Cost-effectiveness analysis of sensor-augmented insulin pump therapy with automated insulin suspension versus standard insulin pump therapy in patients with type 1 diabetes in Sweden","volume":"8","author":"Jendle","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.endinu.2018.03.008_bib0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/dia.2015.0224","article-title":"Cost-effectiveness of sensor-augmented pump therapy with low glucose suspend versus standard insulin pump therapy in two different patient populations with type 1 diabetes in France","volume":"18","author":"Roze","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2018.03.008_bib0300","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/erp.10.73","article-title":"Economic impact of hypoglycemia on healthcare in Spain","volume":"10","author":"Brito-Sanfiel","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001641830096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001641830096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:05:09Z","timestamp":1762866309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253001641830096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S253001641830096X"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2018.03.008","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}